Moxibustion Plus Cupping in Convalescent Patients With COVID-19

NCT04374084 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-11-24

No results posted yet for this study

Summary

This trial is designed to evaluate the efficacy and safety of moxibustion plus cupping in the convalescence of COVID-19.

Conditions

Interventions

OTHER

Moxibustion plus Cupping

Moxibustion: The burning of a small, thimble sized, smoldering plug of dried leaves on the skin at an acupuncture point. Usually the plugs contain leaves of mugwort or moxa. Cupping takes the pot as a tool, uses the combustion to remove the air in the pot, causes a negative pressure, and makes it adsorb on the skin of the acupoints. Use"Baixiaojiu"moxibustion on each acupoint for 10-15 minutes, the temperature of moxibustion should be adjusted within patient's tolerance level. Use diameter of 5-6 cm acuum cupper to cupping on each acupoint for 5-8 minutes.

Sponsors & Collaborators

  • Hubei Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Hubei Provincial Hospital of Integrated Chinese & Western Medicine

    collaborator UNKNOWN
  • Wuhan Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Wuhan Third Hospital

    collaborator OTHER
  • Huangshi Hospital of Traditional Chinese Medicine

    collaborator UNKNOWN
  • Yichang Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Ezhou Hospital of Traditional Chinese Medicine

    collaborator UNKNOWN
  • Hunan University of Traditional Chinese Medicine

    collaborator OTHER
  • The Hospital of Jiangxi University of Chinese Medicine

    collaborator UNKNOWN
  • Guang'anmen Hospital of China Academy of Chinese Medical Sciences

    lead OTHER

Principal Investigators

  • Xiaopin Wang · Guang'anmen Hospital of China Academy of Chinese Medical Sciences

  • Zhongyu Zhou · Hubei Hospital of Traditional Chinese Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-10
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04374084 on ClinicalTrials.gov